Breast cancer is a heterogeneous disease that can be classified into four subtypes according to histological features, including luminal A, luminal B, human epidermal growth factor receptor 2 (HER2)-positive and triple-negative breast cancer (TNBC). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.